Literature DB >> 10670461

Self-destructive and self-protective processes in the damaged optic nerve: implications for glaucoma.

M Schwartz1, E Yoles.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10670461

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN： 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  6 in total

1.  Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma.

Authors:  H Schori; J Kipnis; E Yoles; E WoldeMussie; G Ruiz; L A Wheeler; M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

2.  Antiphosphatidylserine antibodies are elevated in normal tension glaucoma.

Authors:  S Kremmer; E Kreuzfelder; R Klein; N Bontke; K B Henneberg-Quester; K P Steuhl; H Grosse-Wilde
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

3.  T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies.

Authors:  J Kipnis; E Yoles; Z Porat; A Cohen; F Mor; M Sela; I R Cohen; M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

4.  Sensitized heat shock protein 27 induces retinal ganglion cells apoptosis in rat glaucoma model.

Authors:  Wei Zhao; Le Dai; Xiao-Ting Xi; Qian-Bo Chen; Mei-Xia An; Yan Li
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

5.  Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma.

Authors:  Fabian Anders; Julia Teister; Aiwei Liu; Sebastian Funke; Franz H Grus; Solon Thanos; Harald D von Pein; Norbert Pfeiffer; Verena Prokosch
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

6.  Crystallins are regulated biomarkers for monitoring topical therapy of glaucomatous optic neuropathy.

Authors:  Verena Prokosch; Maurice Schallenberg; Solon Thanos
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.